Telangana CM Revanth Reddy and his government have secured a massive investment in the pharma sector. Global pharmaceutical giant Eli Lilly has announced a $1 billion (around ₹9,000 crore) investment in Hyderabad.
The company will set up a manufacturing and quality hub to boost local production of key medicines and a technology and innovation hub to harness India’s growing talent in AI and data science.
This move is part of Eli Lilly’s global expansion strategy and a step towards meeting rising demand while competing with Indian generic manufacturers.
The agreement was signed in the presence of CM Revanth Reddy and IT Minister Sridhar Babu. Recruitment for the new facility will begin soon, with plans to hire 1,500 professionals over the next few years including engineers, chemists, analytical scientists, quality control experts, and managers for its Global Capacity Center (GCC).
